Maintenance. We are currently updating the site. Please check back shortly
Members login
  • TrustLaw
  • Members Portal
Subscribe Donate

UPDATE 1-U.S. FDA to reexamine metal dental fillings

Source: Thomson Reuters Foundation - Fri, 10 Dec 2010 14:36 GMT
Author: (c) Copyright Thomson Reuters 2010. Click For Restrictions. http://about.reuters.com/fulllegal.asp
hum-peo
Tweet Recommend Google + LinkedIn Email Print
Leave us a comment

* FDA to ask advisers about data, mercury exposure

* Could affect Dentsply, Danaher's Kerr, others

* Advisory panel will weigh issue Tuesday and Wednesday (Updates with background, paragraphs 4-11)

By Susan Heavey

WASHINGTON, Dec 10 (Reuters) - U.S. health regulators are seeking a second opinion on whether mercury-containing dental fillings pose a risk to dental patients, especially children and pregnant women.

Food and Drug Administration officials said that while there are no new scientific findings on such silver-colored cavity fillings, it wants feedback on methods it used to weigh available data and decide last year that the metal alloy is safe.

In documents released on Friday ahead of a public meeting on the issue, the agency said it would ask its panel of outside experts to asses how much mercury dental patients are exposed to and how much exposure is acceptable.

The FDA reversed course in July 2009 and declared the fillings, known as dental amalgam, posed no risk. Earlier, it cautioned against their use in certain more vulnerable people such as pregnant women and children.

The agency is revisiting the issue after four groups questioned its assessment and petitioned for a second look. On Tuesday and Wednesday next week, the panel of outside experts will consider available data as well as the agency's interpretation before offering recommendations.

"Based on its own review and feedback from the panel, FDA will decide whether to make changes to its regulation," Nancy Stade, deputy director of policy for the FDA's device center, told reporters on Thursday. "At this time, the FDA is not modifying its existing recommendations to consumers."

Millions of Americans have had cavities in their teeth patched with the lower-cost dental amalgam. Other options include bone-colored resin.

FDA could decide to continue backing the metal fillings, again urge more cautious use, or ban the products.

Any reversal could affect dental filling makers such as Dentsply International Inc <XRAY.O> and Danaher Corp's <DHR.N> Kerr unit, and distributors such as Henry Schein Inc <HSIC.O> and Patterson Cos Inc <PDCO.O>.

Mercury is a known toxin. At issue is whether the vapors released from mercury in dental fillings are enough to cause harm such as brain or kidney damage.

While some experts and advocacy groups say mounting data show a clear link between mercury and side effects, and that dental fillings are no exception, industry groups and dentists say the evidence shows dental amalgam is safe. (Reporting by Susan Heavey; Editing by John Wallace)

We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of the Thomson Reuters Foundation. For more information see our Acceptable Use Policy.

comments powered by Disqus
Most Popular
TOPICAL CONTENT
Topical content
LATEST SLIDESHOW

Latest slideshow

See allSee all
FEATURED JOBS
Featured jobs